Matrix Metalloproteinase 1
"Matrix Metalloproteinase 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A member of the metalloproteinase family of enzymes that is principally responsible for cleaving FIBRILLAR COLLAGEN. It can degrade interstitial collagens, types I, II and III.
| Descriptor ID |
D020781
|
| MeSH Number(s) |
D08.811.277.656.300.480.205.351 D08.811.277.656.300.480.525.700.100 D08.811.277.656.675.374.205.351 D08.811.277.656.675.374.525.700.100 D12.644.276.848.100 D12.776.467.836.100
|
| Concept/Terms |
Matrix Metalloproteinase 1- Matrix Metalloproteinase 1
- Metalloproteinase 1, Matrix
- Interstitial Collagenase
- MMP1 Metalloproteinase
- Metalloproteinase, MMP1
- MMP-1 Metalloproteinase
- MMP 1 Metalloproteinase
- Metalloproteinase, MMP-1
- Matrix Metalloproteinase-1
Pro-Matrix Metalloproteinase-1- Pro-Matrix Metalloproteinase-1
- Metalloproteinase-1, Pro-Matrix
- Pro Matrix Metalloproteinase 1
- Promatrixmetalloproteinase-1
- Promatrixmetalloproteinase 1
- proMMP-1
|
Below are MeSH descriptors whose meaning is more general than "Matrix Metalloproteinase 1".
Below are MeSH descriptors whose meaning is more specific than "Matrix Metalloproteinase 1".
This graph shows the total number of publications written about "Matrix Metalloproteinase 1" by people in this website by year, and whether "Matrix Metalloproteinase 1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 2 | 2 |
| 2010 | 1 | 1 | 2 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 3 | 3 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Matrix Metalloproteinase 1" by people in Profiles.
-
Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1). Front Immunol. 2021; 12:593595.
-
Molecularly engineered self-assembling membranes for cell-mediated degradation. Adv Healthc Mater. 2015 Mar 11; 4(4):602-12.
-
Detection of relaxin receptor in the dorsoradial ligament, synovium, and articular cartilage of the trapeziometacarpal joint. J Orthop Res. 2014 Aug; 32(8):1061-7.
-
Relationship of relaxin hormone and thumb carpometacarpal joint arthritis. Clin Orthop Relat Res. 2014 Apr; 472(4):1130-7.
-
Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival. J Cancer Res Clin Oncol. 2013 Aug; 139(8):1373-82.
-
Plasma matrix metalloproteinases and postmenopausal breast cancer risk: a nested case-control study in the Multiethnic Cohort study. Breast Cancer Res Treat. 2012 Dec; 136(3):837-45.
-
Tocotrienol vitamin E protects against preclinical canine ischemic stroke by inducing arteriogenesis. J Cereb Blood Flow Metab. 2011 Nov; 31(11):2218-30.
-
Tumor cell invasion is promoted by interstitial flow-induced matrix priming by stromal fibroblasts. Cancer Res. 2011 Feb 01; 71(3):790-800.
-
SPARC-derived protease substrates to enhance the plasmin sensitivity of molecularly engineered PEG hydrogels. Biomaterials. 2011 Feb; 32(5):1301-10.
-
Enhanced proteolytic degradation of molecularly engineered PEG hydrogels in response to MMP-1 and MMP-2. Biomaterials. 2010 Oct; 31(30):7836-45.